Publications

• A novel acridine flow cytometry marker to track post-transfusion amustaline/glutathione pathogen-reduced red blood cell survival in sickle cell disease patients.
  Transfusion
  04/18/2025 Authors: Benjamin RJ; Pitman JP; Karim C; Huang S; Erickson A; Corash L; Mufti N; Roback JD; Zerra PE; Fasano RM
• Therapeutic plasma exchange for fibrinogen-associated hyperviscosity: results of the COVID-19 PLasma EXchange (COPLEX)randomized controlled trial.
  J Thromb Haemost Volume: 23 Page(s): 1393 - 1400
  04/01/2025 Authors: Maier CL; Nakahara H; Barker NA; Auld SC; Truong AD; Friend S; Caridi-Scheible M; Connor M; Gaddh M; Cobb J
• CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion.
  Front Immunol Volume: 16 Page(s): 1548548
  01/01/2025 Authors: Jajosky RP; Covington ML; Liu J; Chai L; Zerra PE; Chonat S; Stowell SR; Arthur CM
• Harnessing the potential of red blood cells in immunotherapy.
  Hum Immunol Volume: 85 Page(s): 111084
  11/01/2024 Authors: Jajosky RP; Zerra PE; Chonat S; Stowell SR; Arthur CM
• Development and evaluation of trigger tools to identify pediatric blood management errors.
  Blood Transfus Volume: 22 Page(s): 484 - 491
  11/01/2024 Authors: Kandaswamy S; Josephson CD; Rollins MR; Jones J; Zerra P; Goel R; Andrews J; Hendrickson JE; Lieberman L; Orenstein EW
• Marginal Zone B Cells Represent a Conserved Initiating Player in the Immune Response to Factor VIII in Hemophilia A Mice.
  Thromb Haemost Volume: 124 Page(s): 893 - 896
  09/01/2024 Authors: Maarouf M; Patel SR; Baldwin WH; Zerra PE; Cox C; Parker ET; Stowell SR; Meeks SL
• Survival of transfused red blood cells from a donor with alpha-thalassemia trait in a recipient with sickle cell disease.
  Transfusion Volume: 64 Page(s): 1109 - 1115
  06/01/2024 Authors: Yee MEM; Covington ML; Zerra PE; McCoy JW; Easley KA; Joiner CH; Bryksin J; Francis RO; Lough CM; Patel N
• Post-transfusion biotin-labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance.
  Transfusion Volume: 64 Page(s): 800 - 807
  05/01/2024 Authors: Yee MEM; Zerra PE; McCoy JW; Covington ML; Stowell SR; Joiner CH; Lough CM; Delvadia BB; Josephson CD; Roback JD
• Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression.
  Blood Volume: 142 Page(s): 1082 - 1098
  09/21/2023 Authors: Jajosky RP; Patel KR; Allen JWL; Zerra PE; Chonat S; Ayona D; Maier CL; Morais D; Wu S-C; Luckey CJ
• USE OF CAPLACIZUMAB IN PEDIATRIC THROMBOTIC THROMBOCYTOPENIC PURPURA PATIENTS
  Volume: 70 Page(s): S139 - S139
  06/01/2023 Authors: Graciaa S; Sidonio R; Zerra P; Rollins M; Briones M; Chonat S
• Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice.
  Volume: 141 Page(s): 2642 - 2653
  05/25/2023 Authors: Jajosky R; Patel SR; Wu S-C; Patel K; Covington M; Vallecillo-Zniga M; Ayona D; Bennett A; Luckey CJ; Hudson KE
• Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C).
  Am J Hematol Volume: 98 Page(s): E98 - E101
  05/01/2023 Authors: Zerra PE; Stowell J; Verkerke H; McCoy J; Jones J; Graciaa S; Lu A; Hussaini L; Anderson EJ; Rostad CA
• Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice.
  Transfusion Volume: 63 Page(s): 457 - 462
  03/01/2023 Authors: Maier CL; Jajosky RP; Patel SR; Verkerke HP; Fuller MD; Allen JW; Zerra PE; Fasano RM; Chonat S; Josephson CD
• Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology center.
  Pediatr Blood Cancer Volume: 69 Page(s): e29992
  12/01/2022 Authors: Graciaa S; Adeagbo S; Fong G; Rollins M; McElfresh P; Zerra PE; Bennett C; Josephson CD; Briones M; Fasano RM
• Indeterminate group A subtyping for prospective renal transplant donor.
  Transfusion Volume: 62 Page(s): 1927 - 1928
  09/01/2022 Authors: Achram R; Zerra PE; Delvadia B; Thompson L; Badell IR; Roback JD; Sullivan HC
• Engineering a Therapeutic Protein to Enhance the Study of Anti-Drug Immunity.
  Biomedicines Volume: 10
  07/18/2022 Authors: Zerra PE; Parker ET; Baldwin WH; Healey JF; Patel SR; McCoy JW; Cox C; Stowell SR; Meeks SL
• Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice.
  Transfusion Volume: 62 Page(s): 948 - 953
  05/01/2022 Authors: Arthur CM; Patel SR; Sharma A; Zerra PE; Chonat S; Jajosky RP; Fasano RM; Patel R; Bennett A; Zhou X
• Nonhuman glycans can regulate anti-factor VIII antibody formation in mice.
  Blood Volume: 139 Page(s): 1312 - 1317
  03/03/2022 Authors: Arthur CM; Zerra PE; Shin S; Wang J; Song X; Doering CB; Lollar P; Meeks S; Stowell SR
• Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange.
  Transfusion Volume: 62 Page(s): 584 - 593
  03/01/2022 Authors: Wade J; Yee MEM; Easley KA; Pahz S; Butler H; Zerra PE; Josephson CD; Fasano RM
• Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway.
  Front Immunol Volume: 13 Page(s): 880829
  01/01/2022 Authors: Patel SR; Lundgren TS; Baldwin WH; Cox C; Parker ET; Healey JF; Jajosky RP; Zerra PE; Josephson CD; Doering CB
• Adverse Events in Pediatric Patients with Sickle Cell Disease Undergoing Chronic Automated Red Cell Exchange
  Volume: 61 Page(s): 207A - 208A
  09/01/2021 Authors: Wade J; Yee MM; Pahz S; Butler H; Zerra PE; Josephson CD; Fasano RM
• Prioritizing Pediatric Patient Blood Management Errors For Automated Surveillance: A Modified Delphi Study
  Volume: 61 Page(s): 158A - 158A
  09/01/2021 Authors: Kandaswamy S; Orenstein EW; Rollins MR; Jones J; Zerra PE; Goel R; Andrews J; Hendrickson J; Lani L; Josephson CD
• Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.
  Blood Volume: 138 Page(s): 706 - 721
  08/26/2021 Authors: Zerra PE; Patel SR; Jajosky RP; Arthur CM; McCoy JW; Allen JWL; Chonat S; Fasano RM; Roback JD; Josephson CD
• COMPLEMENT IN THROMBOTIC MICROANGIOPATHIES
  Volume: 68 Page(s): S111 - S111
  06/01/2021 Authors: Graciaa S; Zerra P; Fasano R; Chonat S
• Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma.
  Transfusion Volume: 61 Page(s): 1740 - 1748
  06/01/2021 Authors: Verkerke H; Saeedi BJ; Boyer D; Allen JW; Owens J; Shin S; Horwath M; Patel K; Paul A; Wu S-C
• An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.
  Immunohematology Volume: 37 Page(s): 33 - 43
  03/01/2021 Authors: Ho AD; Verkerke H; Allen JW; Saeedi BJ; Boyer D; Owens J; Shin S; Horwath M; Patel K; Paul A
• Transfusion in Neonatal Patients: Review of Evidence-Based Guidelines.
  Clin Lab Med Volume: 41 Page(s): 15 - 34
  03/01/2021 Authors: Zerra PE; Josephson CD
• Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.
  Blood Adv Volume: 5 Page(s): 527 - 538
  01/26/2021 Authors: Arthur CM; Allen JWL; Verkerke H; Yoo J; Jajosky RP; Girard-Pierce K; Chonat S; Zerra P; Maier C; Rha J
• Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease.
  Haematologica Volume: 105 Page(s): 2887 - 2891
  12/01/2020 Authors: Chonat S; Graciaa S; Shin HS; Newton JG; Quarmyne M-O; Boudreaux J; Tang A; Zerra PE; Rollins MR; Josephson CD
• Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease.
  Haematologica
  07/30/2020 Authors: Chonat S; Graciaa S; Shin HS; Newton JG; Quarmyne M-O; Boudreaux J; Tang A; Zerra PE; Rollins MR; Josephson CD
• Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation.
  Front Immunol Volume: 11 Page(s): 905
  01/01/2020 Authors: Zerra PE; Arthur CM; Chonat S; Maier CL; Mener A; Shin S; Allen JWL; Baldwin WH; Cox C; Verkerke H
• Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome.
  Front Pediatr Volume: 8 Page(s): 616731
  01/01/2020 Authors: Raghunandan S; Josephson CD; Verkerke H; Linam WM; Ingram TC; Zerra PE; Arthur CM; Stowell SR; Briones M; Chonat S
• Mechanisms of Antibody-Mediated RBC Removal: Consequences on Prevention and Treatment
  Volume: 59 Page(s): 13A - 14A
  09/01/2019 Authors: Chonat S; Arthur C; Fuller M; Jajosky R; Zerra P; Maier CL; Stowell S
• FVIII-specific CD4 T cell proliferation requires multiple previous exposures to FVIII
  Volume: 25 Page(s): 76 - 76
  07/01/2019 Authors: Zerra P; Patel S; Baldwin W; Healey J; Parker E; Cox C; Lollar P; Stowell S; Meeks S
• Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
  Transfus Clin Biol Volume: 26 Page(s): 130 - 134
  05/01/2019 Authors: Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R
• Neonatal and Pediatric Transfusion Medicine
  Page(s): 295 - 299
  01/01/2019 Authors: Zerra PE; Hendrickson JE; Josephson CD
• Vascular Bleeding Disorders
  Page(s): 719 - 722
  01/01/2019 Authors: Zerra PE; Briones MA
• Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.
  JCI Insight Volume: 3
  11/15/2018 Authors: Mener A; Patel SR; Arthur CM; Chonat S; Wieland A; Santhanakrishnan M; Liu J; Maier CL; Jajosky RP; Girard-Pierce K
• Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.
  Blood Adv Volume: 2 Page(s): 105 - 115
  01/23/2018 Authors: Patel SR; Bennett A; Girard-Pierce K; Maier CL; Chonat S; Arthur CM; Zerra PE; Mener A; Stowell SR
• Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion.
  Front Immunol Volume: 9 Page(s): 2516
  01/01/2018 Authors: Patel SR; Gibb DR; Girard-Pierce K; Zhou X; Rodrigues LC; Arthur CM; Bennett AL; Jajosky RP; Fuller M; Maier CL
• Primed CD4 T Cells to an Intracellular Alloantigen Facilitate Alloimmunization Following Subsequent Transfusion
  Volume: 130
  12/07/2017 Authors: Patel SR; Bennett AL; Zerra PE; Chonat S; Maier C; Stowell SR
• Marginal Zone B Cells Facilitate RBC Alloimmunization Independent of Direct CD4(+) T Cell Activation
  Volume: 130
  12/07/2017 Authors: Zerra PE; Patel SR; Bennett AL; Stowell SR
• Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A.
  Blood Volume: 130 Page(s): 2559 - 2568
  12/07/2017 Authors: Zerra PE; Cox C; Baldwin WH; Patel SR; Arthur CM; Lollar P; Meeks SL; Stowell SR
• Primed CD4 T Cells to One RBC Alloantigen Can Enhance Subsequent Alloimmunization
  Volume: 57 Page(s): 9A - 10A
  09/01/2017 Authors: Patel SR; Bennett A; Girard-Pierce K; Arthur C; Mener A; Zerra P; Tormey CA; Hendrickson J; Stowell S
• Marginal Zone B Cells Regulate RBC Alloimmunization Toward Distinct RBC Alloantigens
  Volume: 128
  12/02/2016 Authors: Zerra PE; Patel SR; Arthur CM; Girard-Pierce KR; Bennett A; Stowell SR
• Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
  Pediatr Blood Cancer Volume: 63 Page(s): 712 - 715
  04/01/2016 Authors: Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
• Marginal Zone B Cell Depletion Prevents Factor VIII Inhibitor Development in Model of Hemophilia
  Volume: 126
  12/03/2015 Authors: Cox C; Zerra P; Authur C; Patel S; Meeks S; Stowell SR
• Antigen Density Impacts RBC Survival and Antigen Modulation Following Incompatible RBC Transfusion
  Volume: 126
  12/03/2015 Authors: Yoo J; Arthur CM; Zerra P; Girard-Pierce K; Hendrickson JE; Stowell SR
• An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.
  Expert Opin Pharmacother Volume: 14 Page(s): 1497 - 1513
  08/01/2013 Authors: Zerra P; Cochran TR; Franco VI; Lipshultz SE
• Knocking down myotubularin, a gene mutated in myotubular myopathy, results in transcriptional up-regulation of doublecortin.
  Volume: 68 Page(s): A403 - A404
  03/20/2007 Authors: Tomczak KK; Pierson CR; Buj-Bello A; Zerra PE; Sanoudou D; Moghadaszadeh B; Laporte J; Beggs AH
• SiRNA knockdown of myotubularin results in transcriptional but not morphologic changes during myogenic differentiation in C2C12 cells
  Volume: 19 Page(s): A503 - A503
  03/04/2005 Authors: Tomczak K; Zerra PE; Buj-Bello A; Pierson CR; Sanoudou D; Laporte J; Mandel JL